JB
John K Bell
Director

John K Bell insider trades: DelMar Pharmaceuticals (DMPI) stock purchases

Director, DelMar Pharmaceuticals Last trade Sep 13, 2019 36 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
11
Open-market trades
since 2014
2
Companies
last trade 2019

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where John reports to the SEC

Open-market buys and sales

11 trades reported on SEC Form 4, newest first

DateStockTypeValue
Sep 13, 2019DMPI↑ Buy$24K
Nov 16, 2017DMPI↑ Buy$16K
Jun 26, 2017DMPI↑ Buy$15K
Jun 6, 2017DMPI↑ Buy$21K
Jul 16, 2015DMPI↑ Buy$30K
Nov 21, 2014DMPI↑ Buy$8K
Sep 8, 2014DMPI↑ Buy$5K
Sep 4, 2014DMPI↑ Buy$6K
Apr 22, 2014DMPI↑ Buy$25K
Mar 18, 2014DMPI↑ Buy$33K
Feb 11, 2014DMPI↑ Buy$8K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About John K Bell's insider trades

John K Bell is a director at DelMar Pharmaceuticals (DMPI). Since Feb 11, 2014, John has reported 11 open-market purchases worth $190K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include other transactions (19 filings), grants and awards (6 filings), conversions (2 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every DMPI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.